Melatoninas Pharma Nord

Melatonin, the active ingredient in Melatoninas Pharma Nord, is a melatonin receptor agonist presented as an oral tablet for oral use. It is employed to support the regulation of sleep‑wake cycles and to aid individuals experiencing difficulty initiating or maintaining sleep.

GNH USA supplies Melatoninas Pharma Nord as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for regulated markets. Customers benefit from comprehensive documentation, traceability and responsive technical support throughout the procurement process.

Melatonin acts on the melatonin receptor system to regulate circadian rhythm and is indicated for several sleep‑related conditions.

- Insomnia: helps reduce sleep onset latency and improve sleep continuity in adults. - Circadian rhythm sleep disorders: assists in aligning the internal clock with external light‑dark cycles. - Jet lag: facilitates faster adjustment to new time zones after long‑distance travel.

Melatonin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Dizziness: transient sensation of light‑headedness. - Nausea: occasional stomach upset. - Daytime sleepiness: residual drowsiness after dosing. - Vivid dreams: unusual or intense dreaming patterns. - Mild gastrointestinal discomfort: abdominal cramping or bloating.

Serious or Rare Side Effects: - Allergic reaction: rash, itching, or swelling. - Severe rash: Stevens‑Johnson‑type skin eruption. - Depression: worsening mood or depressive symptoms. - Hallucinations: visual or auditory disturbances. - Worsening of sleep apnea: increased breathing interruptions during sleep. - Suicidal thoughts: emergence of self‑harm ideation.

Before initiating therapy, consider the following safety measures.

- Assess medical history: evaluate for depression, seizure disorders, or severe hepatic impairment. - Review concurrent medications: identify agents that may potentiate sedation. - Pregnancy and lactation: discuss potential risks with a healthcare professional. - Pediatric use: limit to ages and doses recommended by a prescriber. - Elderly patients: start with the lowest effective dose and monitor for confusion. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Melatonin may interact with other medicines; some combinations require avoidance while others need monitoring.

Major Interactions (Avoid): - CNS depressants: additive sedation may occur. - Anticoagulants: possible increase in bleeding risk. - Immunosuppressants: melatonin may alter immune modulation.

Moderate Interactions (Monitor Closely): - Oral contraceptives: melatonin may reduce contraceptive efficacy. - CYP1A2 inhibitors (e.g., fluvoxamine): may raise melatonin plasma levels. - CYP1A2 inducers (e.g., smoking, carbamazepine): may lower melatonin exposure.